- Home
- ESPR vs SSBK Comparison
ESPR vs SSBK Comparison
Compare ESPR & SSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- SSBK
- Stock Information
- Founded
- ESPR 2008
- SSBK 2007
- Country
- ESPR United States
- SSBK United States
- Employees
- ESPR N/A
- SSBK N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- SSBK Commercial Banks
- Sector
- ESPR Health Care
- SSBK Finance
- Exchange
- ESPR Nasdaq
- SSBK Nasdaq
- Market Cap
- ESPR 305.0M
- SSBK 330.0M
- IPO Year
- ESPR 2013
- SSBK 2021
- Fundamental
- Price
- ESPR $1.50
- SSBK $32.06
- Analyst Decision
- ESPR Buy
- SSBK Buy
- Analyst Count
- ESPR 7
- SSBK 1
- Target Price
- ESPR $6.36
- SSBK $36.00
- AVG Volume (30 Days)
- ESPR 3.9M
- SSBK 12.5K
- Earning Date
- ESPR 03-04-2025
- SSBK 04-21-2025
- Dividend Yield
- ESPR N/A
- SSBK 1.13%
- EPS Growth
- ESPR N/A
- SSBK 3.86
- EPS
- ESPR N/A
- SSBK 3.67
- Revenue
- ESPR $332,314,000.00
- SSBK $94,140,000.00
- Revenue This Year
- ESPR $5.51
- SSBK $19.13
- Revenue Next Year
- ESPR $1.42
- SSBK $7.78
- P/E Ratio
- ESPR N/A
- SSBK $8.66
- Revenue Growth
- ESPR 185.66
- SSBK 13.56
- 52 Week Low
- ESPR $1.47
- SSBK $22.13
- 52 Week High
- ESPR $3.94
- SSBK $39.16
- Technical
- Relative Strength Index (RSI)
- ESPR 34.95
- SSBK 48.74
- Support Level
- ESPR $1.47
- SSBK $31.10
- Resistance Level
- ESPR $1.61
- SSBK $32.67
- Average True Range (ATR)
- ESPR 0.13
- SSBK 0.80
- MACD
- ESPR -0.01
- SSBK 0.04
- Stochastic Oscillator
- ESPR 7.69
- SSBK 59.00
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About SSBK Southern States Bancshares Inc.
Southern States Bancshares Inc is a full-service community banking institution, that offers an array of deposit, loan, and other banking-related products and services to businesses and individuals in communities. It has three portfolio segments Real estate, Commercial and industrial, Consumer and other.